Inhibition of adjuvant-induced polyarthritis with cytarabine.
D000276:Adjuvants, Immunologic; D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy*; D001831:Body Temperature / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy; D007249:Inflammation / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats
D000276:Adjuvants, Immunologic; D003561:Cytarabine; D003520:Cyclophosphamide; D010653:Phenylbutazone; D008775:Methylprednisolone